Exercise training in patients with non-small cell lung cancer during in-hospital chemotherapy treatment: a randomized controlled trial.

Not Applicable

Completed

• Conditions: Cancer - Lung - Non small cell; lung cancer; Physical Medicine / Rehabilitation - Physiotherapy

• Registration Number: ACTRN12616001512415
• Lead Sponsor: Medical University of Silesia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

ability to perform the 6 minute walk test, Eastern Cooperative Oncology Group performance status 0-1 and ability to complete self-questionnaires and willingness to participate/ cooperate in the study

Exclusion Criteria

uncontrolled hypertension or unstable coronary artery disease, anaemia (HB< 10g/dl), severe osteoarthritis and bone metastases or CNS metastases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
physical fitness (endurance, fatigue) assessed using Functional Fitness Test[1. baseline - Initial assessment of the patient, Chemotherapy session (1 week home care)<br>2. 3 weeks - Assessment of the patient after rehabilitation– physical fitness assessment.<br>3. 6 weeks - Final assessment of patient after 6 weeks– including physical fitness assessment<br>];Lung function (composite of FEV1, FVC, FEV1%FVC) assessed using spirometry[1. baseline - Initial assessment of the patient,<br>2. 3 weeks - Assessment of the patient after rehabilitation– lung function assessment.<br>3. 6 weeks - Final assessment of patient after 6 weeks– lung function assessment]; dyspnea assessed using MRC, BDI, Borg Scale[1. baseline - Initial assessment of the patient,<br>2. 3 weeks - Assessment of the patient after rehabilitation– dyspnea assessment.<br>3. 6 weeks - Final assessment of patient after 6 weeks– dyspnoea assessment]

Secondary Outcome Measures

Name	Time	Method
quality of life assessed using St George's Respiratory Questionnaire, SF-36, Functional Assessment of Cancer Therapy - Lung (FACT-L)[1. baseline - Initial assessment of the patient,<br>2. 6 weeks - Final assessment of patient after 6 weeks– quality of life]